We found 198 resources matching your search…

Sort by
Investment Management
The 60/40 debate: Is it still relevant?
Equity-bond diversification is still a strong strategy for investors.
Visit arrow right black
Investment Management
Active advantage on short-term opportunities
Is flexibility the key to strong returns?
Visit arrow right black
Investment Management
A dose of clarity for pharma investors
European pharmaceuticals have dodged steep tariff threats.
Visit arrow right black
Investment Management
How far will the revival in European equities go?
Will fiscal firepower spark the continent’s equity revival?
Visit arrow right black
Investment Management
Peace talks trigger defence stock slumps
Is the dip hiding defence’s long-term momentum?
Visit arrow right black
Investment Management
Will Europe continue to benefit as investors avoid Mag 7?
Where are investors seeking diversification?
Visit arrow right black
Investment Management
Pharma stocks brace for pricing pressure following Trump ultimatums
How will pricing reforms reshape the sector?
Visit arrow right black
Investment Management
Sustainable stocks in the spotlight
Support the change to a more sustainable society.
Download arrow right black
Investment Management
Undervalued stocks in Europe’s defence drive
Which equities remain cheap despite the continent’s spending spree?
Visit arrow right black
Investment Management
Sustainable securities shine through the storm
Why did green equities beat their benchmarks?
Visit arrow right black
Investment Management
Which equity factors excelled in Q2?
Returns varied across markets and regions – how should investors prepare for the rest of 2025?
Visit arrow right black
Investment Management
How EU-US trade deal validates recent rally
What long-term impact will tariffs have on equities?
Visit arrow right black
Not a member yet?
Get access to all of the Investment IQ curated content completely free today
IQ logo